Leslie Holsinger
2021
In 2021, Leslie Holsinger earned a total compensation of $603.9K as Executive Vice President of Preclinical Development at Cortexyme, a 93% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $169,850 |
|---|---|
| Salary | $430,000 |
| Other | $4,000 |
| Total | $603,850 |
Holsinger received $430K in salary, accounting for 71% of the total pay in 2021.
Holsinger also received $169.9K in non-equity incentive plan and $4K in other compensation.
Rankings
In 2021, Leslie Holsinger's compensation ranked 10,299th out of 12,415 executives tracked by ExecPay. In other words, Holsinger earned more than 17.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,299 out of 12,415 | 17th |
Division Manufacturing | 4,565 out of 5,508 | 17th |
Major group Chemicals And Allied Products | 2,042 out of 2,378 | 14th |
Industry group Drugs | 1,811 out of 2,099 | 14th |
Industry Biological Products, Except Diagnostic Substances | 397 out of 449 | 12th |
Pay ratio
| Leslie Holsinger's Pay | $603,850 |
|---|---|
| Median Employee's Pay | $622,098 |
| Pay Ratio | 1to 1 |
In 2021, the annual total compensation of Leslie Holsinger was $603,850.
The annual total compensation of the median employee at Cortexyme was $622,098.
The ratio of Leslie Holsinger's pay to the pay of median employee was therefore 1 to one.
Source: SEC filing on April 27, 2022.
Holsinger's colleagues
We found four more compensation records of executives who worked with Leslie Holsinger at Cortexyme in 2021.